Intestinal Microbiome‐Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background and Aims: Mounting evidence supports an association between cholestatic liver disease and changes in the composition of the microbiome. Still, the role of the microbiome in the pathogenesis of this condition remains largely undefined. Approach and Results: To address this, we have used two experimental models, administering alpha‐naphtylisocyanate or feeding a 0.1% 3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine diet, to induce cholestatic liver disease in germ‐free mice and germ‐free mice conventionalized with the microbiome from wild‐type, specific pathogen‐free animals. Next, we have inhibited macrophage activation by depleting these cells using clodronate liposomes and inhibiting the inflammasome with a specific inhibitor of NOD‐, LRR‐, and pyrin domain‐containing protein 3. Our results demonstrate that cholestasis, the accumulation of bile acids in the liver, fails to promote liver injury in the absence of the microbiome in vivo. Additional in vitro studies supported that endotoxin sensitizes hepatocytes to bile‐acid–induced cell death. We also demonstrate that during cholestasis, macrophages contribute to promoting intestinal permeability and to altered microbiome composition through activation of the inflammasome, overall leading to increased endotoxin flux into the cholestatic liver. Conclusions: We demonstrate that the intestinal microbiome contributes to cholestasis‐mediated cell death and inflammation through mechanisms involving activation of the inflammasome in macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · cited 1×
“Intestinal TJ protein expression is tightly regulated by inflammation.(29) Analysis of individual regions of the intestine in GF + WT mice after ANIT treatment showed low TNF and IL1β expression levels in the duodenum and jejunum that were mildly increased in the ileum and reached the highest concentrations in the col…”
BackgroundMechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759 · cited 1×
“Macrophages represent the first line of defense against invading bacteria, promoting activation of the inflammasome, triggering the interleukin-1 beta (IL1β)-dependent proinflammatory response by cleavage of pro-IL1β by caspase 1.(23,24) Our”
BackgroundSayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Thevaranjan, N., Puchta, A., Schulz, C., Naidoo, A., Szamosi, J. C., Verschoor, C. P., Loukov, D., Schenck, L. P., Jury, J., Foley, K. P., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.03.002 · Cited by 1,322
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110 · cited 1×
“aNIt-INDUCeD CHoleStaSIS pRoMoteS CHaNgeS IN tHe MICRoBIoMe CoMpoSItIoN oF gF + Wt MICe Previous studies have shown that changes in the microbiome are associated with altered TJ protein expression.(30,31) We performed 16s ribosomal RNA (rRNA) sequence analysis of fecal samples with LotuS(32) and found significant taxo…”
BackgroundModulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications
Natividad, J. M. M., & Verdu, E. F. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.007 · Cited by 525 · cited 1×
“aNIt-INDUCeD CHoleStaSIS pRoMoteS CHaNgeS IN tHe MICRoBIoMe CoMpoSItIoN oF gF + Wt MICe Previous studies have shown that changes in the microbiome are associated with altered TJ protein expression.(30,31) We performed 16s ribosomal RNA (rRNA) sequence analysis of fecal samples with LotuS(32) and found significant taxo…”
BackgroundMicrobial shifts in the aging mouse gut
Langille, M. G., Meehan, C. J., Koenig, J. E., Dhanani, A. S., Rose, R. A., Howlett, S. E., & Beiko, R. G. (2014) · Microbiome · doi:10.1186/s40168-014-0050-9 · Cited by 437 · cited 1×
“There is evidence that during aging, increased intestinal permeability and systemic lowgrade inflammation (inflammaging) are associated with decreased microbial diversity.(4,44) However, aged TNF-knockout mice have comparable microbiome composition and intestinal barrier function to young mice,(4) supporting a causati…”
BackgroundTang, R., Wei, Y., Li, Y., Chen, W., Chen, H., Wang, Q., Yang, F., Miao, Q., Xiao, X., Zhang, H., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313332 · Cited by 434 · cited 5×
“6C), in line with findings during cholestasis in PSC and PBC patients.(12-16) Overall, our results show that the increased intestinal permeability and inflammation observed during cholestasis correlated with changes in the microbiome composition.”
BackgroundResultInfluential
Cited by
Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Labiano, I., Agirre-Lizaso, A., Olaizola, P., Echebarria, A., Huici-Izagirre, M., Olaizola, I., Esparza-Baquer, A., Sharif, O., Hijona, E., Milkiewicz, P., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.044 · Cited by 78
Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review
Hashemi, D., Fard, M. V., Mohammadhasani, K., Barati, M., & Nattagh‐Eshtivani, E. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70092 · Cited by 15
Metadata
- Authors
- Isaacs‐Ten, A., Echeandia, M., Moreno‐Gonzalez, M., Brion, A., Goldson, A., Philo, M., Patterson, A. M., Parker, A., Galduroz, M., Baker, D., Rushbrook, S. M., Hildebrand, F., & Beraza, N.
- Venue
- Hepatology
- Published
- 2020-12
- Volume
- 72
- Issue
- 6
- Pages
- 2090-2108
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3010807724
- Cited by
- 80
- References
- 19
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.